NCT03452514View on ClinicalTrials.gov

Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT

CompletedOBSERVATIONAL
Enrollment

479

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

September 14, 2020

Study Completion Date

September 15, 2020

Conditions
Lung Cancer
Trial Locations (4)

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01805

Lahey Hospital & Medical Center, Burlington

Sponsors
All Listed Sponsors
lead

Hummingbird Diagnostics

INDUSTRY

NCT03452514 - Addition of microRNA Blood Test to Lung Cancer Screening Low Dose CT | Biotech Hunter | Biotech Hunter